SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Credit Suisse Initiates Coverage On CureVac with Neutral Rating, Announces Price Target of $68

Credit Suisse analyst Martin Auster initiates coverage on CureVac (NASDAQ:CVAC) with a Neutral rating and announces Price Target of $68.

· 09/08/2020 05:13
Credit Suisse analyst Martin Auster initiates coverage on CureVac (NASDAQ:CVAC) with a Neutral rating and announces Price Target of $68.